At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
In situ laser assisted fenestrationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Left Subclavian Artery Reconstruction With Laser-assisted Fenestration During the Procedure of Thoracic EndoVascular Aortic Repair for Type B Aortic Dissection
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University·interventional·Posted Feb 19, 2019·Updated Feb 18, 2025
In Brief
A clinical study evaluating In situ laser assisted fenestration for Type B Aortic Dissection. Completed, enrolled 100 participants across 1 site.
Detailed Summary
This study aims to evaluate the feasibility, effectiveness, and safety of in-situ laser-assisted fenestration on the left subclavian artery during the procedure of thoracic artery endovascular repair
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType B Aortic Dissection
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedFeb 2019
Primary CompletionDec 2022
Study CompletionNov 2023
TodayJul 2026
First PostedFeb 19, 2019
Enrollment StartJul 1, 2018
Primary CompletionDec 10, 2022
Study CompletionNov 20, 2023
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 7.4 years ago
Interventions
In situ laser assisted fenestrationprocedure
In situ laser assisted fenestration for the left subclavian artery during the procedure of TEVAR for type B aortic dissection